Cyteir Therapeutics Q2 EPS $(4.83) Down From $(3.18) YoY

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(4.83) per share. This is a 51.89 percent decrease over losses of $(3.18) per share from the same period last year.